초록 ▼

A device for the sustained release in vivo of a water soluble, biologically active agent wherein the agent is susceptible to aggregation comprising a drug delivery device and aggregation-stabilized, biologically active agent wherein the aggregation-stabilized agent is disposed within the drug delive

A device for the sustained release in vivo of a water soluble, biologically active agent wherein the agent is susceptible to aggregation comprising a drug delivery device and aggregation-stabilized, biologically active agent wherein the aggregation-stabilized agent is disposed within the drug delivery device.

대표청구항 ▼

1. A sustained release device of a water soluble, biologically active protein or peptide wherein said protein or peptide is susceptible to aggregation, comprising: a) a biocompatible polymeric matrix; and b) particles of aggregation-stabilized, biologically active protein or peptide which includ

1. A sustained release device of a water soluble, biologically active protein or peptide wherein said protein or peptide is susceptible to aggregation, comprising: a) a biocompatible polymeric matrix; and b) particles of aggregation-stabilized, biologically active protein or peptide which include a biologically active protein or peptide and an aggregation stabilizer, wherein the aggregation-stabilizer is a multivalent metal cation from a metal cation component selected from the group consisting of metal salts, metal hydroxides and basic salts of weak acids having a metal cation, the biologically active protein or peptide and the metal cation are complexed and said particles are disposed within the biocompatible polymeric matrix. 2. A sustained release composition of claim 1 wherein the metal cation is a biocompatible multivalent cation selected from the group consisting of Zn+2,Ca+2,Cu+2,Mg+2and combinations thereof. 3. A sustained release composition of claim 1 further comprising a second metal cation component, wherein the second metal cation component is dispersed within the biocompatible polymeric matrix. 4. A sustained release composition of claim 3 wherein the second metal cation component is selected from the group consisting of magnesium hydroxide, magnesium carbonate, calcium carbonate, zinc carbonate, magnesium acetate, zinc acetate, magnesium sulfate, zinc sulfate, magnesium chloride, zinc chloride, zinc citrate, magnesium citrate and combinations thereof. 5. A sustained release composition of claim 1 wherein the biocompatible polymeric matrix comprises poly(lactide-co-glycolide). 6. The sustained release device of claim 1 wherein the molar ratio of metal cation component to biologically active protein or peptide is from about 1:2 to about 100:1. 7. The sustained release device of claim 6 wherein the molar ratio of metal cation component to biologically active protein or peptide is from about 2:1 to about 10:1. 8. A sustained release device of a water soluble, biologically active protein or peptide wherein said protein or peptide is susceptible to aggregation, comprising: a) a biodegradable polymeric matrix; and b) particles of aggregation-stabilized, biologically active protein or peptide which include a biologically active protein or peptide and an aggregation stabilizer wherein the aggregation-stabilizer is a multivalent metal cation from a metal cation component selected from the group consisting of metal salts, metal hydroxides and basic salts of weak acids having a metal cation, the biologically active protein or peptide and the metal cation are complexed and said particles are disposed within the biodegradable polymeric matrix.